Adipokines as drug targets in diabetes and underlying disturbances.
about
The Macrophage Switch in Obesity DevelopmentExercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular DiseasesCaffeic acid and hydroxytyrosol have anti-obesogenic properties in zebrafish and rainbow trout modelsDiscovery of Novel Insulin Sensitizers: Promising Approaches and Targets.Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients.Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production.Caffeic Acid Phenethyl Ester Regulates PPAR's Levels in Stem Cells-Derived Adipocytes.Non-invasive Assessments of Adipose Tissue Metabolism In VitroAntigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance.GLUT4 Expression in Adipocytes Regulates De Novo Lipogenesis and Levels of a Novel Class of Lipids With Antidiabetic and Anti-inflammatory Effects.Genetic Determination of Serum Levels of Diabetes-Associated AdipokinesCompounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets.Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity.Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.Saponins as adipokines modulator: A possible therapeutic intervention for type 2 diabetes.The Impact of Ghrelin in Metabolic Diseases: An Immune PerspectiveMesenchymal Stem Cells Secretory Responses: Senescence Messaging Secretome and Immunomodulation Perspective.Is There Any Relationship between Plasma 25-Hydroxyvitamin D₃, Adipokine Profiles and Excessive Body Weight in Type 2 Diabetic Patients?The role of oxidative stress on the pathophysiology of metabolic syndrome.Adipose tissue-derived cytokines and their correlations with clinical characteristics in Vietnamese patients with type 2 diabetes mellitus.Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction
P2860
Q26771455-5CEF2C04-CE4F-4A11-B308-C0D358258B3BQ26773005-DDDAA7AC-CD89-4FCD-83C4-9B7265A23662Q33751973-4BEFE048-09BF-4F51-AE84-76C91E963014Q33808884-97F9A1FC-FA9E-4ECC-B874-5C0E96F2495AQ33872738-5CBCE8A2-272C-4428-B48B-41DFC9B8B24BQ36014103-CADA822D-DB6B-4ECB-AA56-3021F4D55889Q36275415-7F97C51F-0619-43E9-A08B-175CA1004351Q36556374-B0CC3EB3-FB92-4587-BB47-5214CD87E25CQ36689334-4CA7889D-7DF9-4E48-B13E-2B19CD987AE5Q36820735-FB999D72-EDFD-4D75-98AA-BD53CF16E615Q37025628-E3B87452-5F16-4934-9682-2045B9435B4EQ38727331-9A775AF7-A422-4A18-91E8-D7641B4077A5Q38833111-39720379-9818-40BB-9254-26AB94D3BAE9Q39038872-455BB335-F6DC-4CE1-BCE9-FE6A74FB06F1Q39175599-B64783FC-6A85-4C2F-9F79-D83CD5112AA1Q39210713-4D8C7BE1-DCC6-4B55-9485-692C520849DFQ39313303-06A53A3A-006F-49EA-B19F-D76D07D19CC5Q40998241-3AA4EE8B-626E-49AA-A0C3-5AB2A68E48DBQ42730636-A45F5FBD-D6D2-4FD0-B2A8-32B5B2EC3B46Q47171898-DBFC35C8-521E-4002-8E9C-54D83857B3B7Q47172465-7DAA40DC-DC6C-4E44-B4DA-6E38E2360ECDQ53749906-D6D4E5C2-1886-4E28-BB3E-B1770AA772E6Q55445346-D51B30C8-1483-4D76-88AA-81C8F30FE74DQ58575454-7FAE6C12-36BB-4EEB-A45A-047B4AA72390
P2860
Adipokines as drug targets in diabetes and underlying disturbances.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adipokines as drug targets in diabetes and underlying disturbances.
@ast
Adipokines as drug targets in diabetes and underlying disturbances.
@en
type
label
Adipokines as drug targets in diabetes and underlying disturbances.
@ast
Adipokines as drug targets in diabetes and underlying disturbances.
@en
prefLabel
Adipokines as drug targets in diabetes and underlying disturbances.
@ast
Adipokines as drug targets in diabetes and underlying disturbances.
@en
P2860
P921
P356
P1476
Adipokines as drug targets in diabetes and underlying disturbances
@en
P2093
Pedro M Moraes-Vieira
P2860
P304
P356
10.1155/2015/681612
P5008
P577
2015-04-08T00:00:00Z